FIELD: medicine. SUBSTANCE: six months not earlier before the flight blood removal is conducted at the quantity of 0.5-2.0% against the body weight. EFFECT: improved activity of astronauts. 3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING PHYSIOLOGICAL EFFECT OF STAYING ON LOW-GRAVITY PLANETARY SURFACE | 2013 |
|
RU2529813C1 |
| METHOD FOR SIMULATING HEMODYNAMIC EFFECTS OF MICROGRAVITY | 2011 |
|
RU2474885C1 |
| ANTI-G TUBELESS SUIT | 2003 |
|
RU2254272C2 |
| METHOD OF IMPLEMENTING INTERPLANETARY MESSAGES AND TECHNICAL DEVICES FOR ITS IMPLEMENTATION | 2019 |
|
RU2737751C2 |
| REDUCED GRAVITY SIMULATION METHOD AND DEVICE FOR ITS IMPLEMENTATION | 2022 |
|
RU2802135C1 |
| METHOD OF ENHANCING HUMAN BODY STABILITY TO INFLUENCES OF GRAVITATIONAL FORCES OF "HEAD-LEGS"-TYPE ON OPERATOR BODY | 1988 |
|
RU2007109C1 |
| VENOUS FLOW STIMULATOR | 2008 |
|
RU2391086C2 |
| METHOD OF PROPHYLAXIS OF NON-FAVORABLE ACTION OF GRAVITATIONAL FORCES ON OPERATOR | 1988 |
|
RU2007108C1 |
| METHOD FOR AUTOMATIZED EVALUATION OF PILOT'S STATE UNDER CONDITIONS OF PILOTING OVERLOADINGS AND DEVICE FOR ITS IMPLEMENTATION | 1996 |
|
RU2111698C1 |
| METHOD OF PROPHYLAXIS OF ADVERSE EFFECT OF ZERO GRAVITY ON HUMAN BEING | 0 |
|
SU972687A1 |
